INS and myocardial infarction: The firstDiabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction studyalso demonstrated an apparent beneficial effect of enhanced insulin-basedglucometabolic control after AMI, which prolonged survival by 2.3 years [30].Therefore, it is critical to monitor the glucose metabolism of CAD patients andintervene as soon as possible to improve the long-term prognosis of high-riskpopulations.